Measurement of pancreatic volume by abdominal MRI: a validation study

Edward W Szczepaniak1, Konstantinos Malliaras, Michael D Nelson

  • 1Cedars-Sinai Medical Center, Los Angeles, California, United States of America.

Plos One
|February 19, 2013
PubMed
Abstract

Insights

A new abdominal magnetic resonance imaging (MRI) protocol accurately measures pancreatic volume in humans and large animals. This non-invasive method shows high reproducibility and potential for obesity and diabetes research.

Area of Science:

  • Medical Imaging
  • Human Physiology
  • Comparative Anatomy

Background:

  • Pancreatic volume is a key indicator in metabolic research.
  • Accurate in vivo measurement of pancreatic volume is challenging.
  • Existing methods have limitations in reproducibility and invasiveness.

Purpose of the Study:

  • To develop and validate a novel abdominal magnetic resonance imaging (MRI) protocol for measuring human pancreatic volume.
  • To assess the accuracy and reproducibility of the developed MRI protocol.
  • To explore correlations between pancreatic volume and metabolic factors.

Main Methods:

  • Abdominal MRI was performed on mini-pigs and humans using a clinical 3T MRI system.
  • Pancreatic volume was calculated from consecutive parallel MRI slices.
  • Validation in mini-pigs involved ex vivo water displacement measurement.
  • Reproducibility in humans was assessed by repeat MRI within 24 hours.

Main Results:

  • MRI-derived pancreatic volume in mini-pigs closely matched water displacement measurements (R² = 0.9867, p < 0.0001).
  • In humans, average pancreatic volume was 72.7 ± 4.5 ml, consistent with prior studies.
  • In vivo measurements demonstrated high reproducibility.
  • Pancreatic volume showed negative correlations with age, body fat mass, pancreatic triglyceride levels, and visceral fat mass.

Conclusions:

  • The developed abdominal MRI protocol provides an accurate and reproducible method for in vivo pancreatic volume estimation.
  • This non-invasive technique holds significant promise for longitudinal studies in obesity and type 2 diabetes research.
  • The protocol may facilitate tracking changes in pancreatic volume and structure over time in relation to metabolic disease progression.